Scientific leader
Pr. Guy Gorochov
Autoimmune diseases represent a significant cost in terms of public health and treatments including steroids and immunosuppressants are (i) extremely deleterious for the comfort of life of patients, and (ii) toxic in the long term. Many autoimmune diseases are caused by aggressive autoimmune antibodies. As part of this program, we propose to “flip” the aggressive antibodies into therapeutic antibodies, by grafting these on immune regulatory cells.
Doc/post-doc
Funding
DIM Thérapie Génique
Laboratory
Team 7 Cellular and molecular immunology of chronic inflammatory diseases
Centre de Recherche CIMI, Sorbonne Université / INSERM
Hôpital Pitié Salpêtrière
Département d’immunologie
83 Boulevard de l’Hôpital
75 013 Paris
